Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Aquestive Therapeutics Inc

(NASDAQ: AQST)
Add to Portfolio
+0.16 (+5.03%)
as of Oct 15, 2019

Last 3.34
Change +0.16 (+5.03%)
Open 3.16
Prev. Close 3.18
Today's Range
3.14
3.39
52wk Range
2.95
18.49
Volume 42,300
Avg Volume 82,550
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
AQST +5.03% +6.71% -77.87%
DJIA +0.89% +5.08% +7.03%
S&P 500 +1.00% +5.31% +8.90%

Key Statistics

Annual EPS -2.61
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 80,890
Weighted Alpha -67.60
Standard Deviation +1.39
Profit Margin N/A
Beta 1.84

Growth Rates

YTD -46.98%
1-Year -76.74%

Opinion

Sell Hold Buy

Recent Headlines

Aquestive Therapeutics Reaffirms Full Year 2019

GlobeNewswire via COMTEX - Tue Oct 15, 05:41PM EDT
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced, in response to Indivior PLC's press (full story)
IZQVF: 0.7060 (+0.1084), AQST: 3.34 (+0.16)

IntelGenx Reports Second Quarter 2019 Financial

GlobeNewswire via COMTEX - Thu Aug 08, 04:00PM EDT
IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today reported financial results for the second quarter ended June 30, 2019. All dollar amounts are expressed i(full story)
IGX.VN: 0.850 (+0.010), IGXT: 0.6600 (+0.0100), TLRY: 22.12 (+1.46), AQST: 3.34 (+0.16)

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops

ZACKS - Tue Aug 06, 08:05PM EDT
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -22.39% and 6.45%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?(full story)
AQST: 3.34 (+0.16)

Will Aquestive Therapeutics (AQST) Report Negative

ZACKS - Wed Jul 31, 10:36AM EDT
Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.(full story)
AQST: 3.34 (+0.16)

Aquestive Therapeutics to Announce Second Quarter 2019

PRNW - Thu Jul 18, 02:23PM EDT
WARREN, N.J. , July 18, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products based on its proprietary Phar(full story)
AQST: 3.34 (+0.16)